Pulmonary Vasculitis on Intralipid Therapy

To the Editor: The article by Redline and Dahms, “Malassezia Pulmonary Vasculitis in an Infant on Long-Term Intralipid Therapy” (December 3 issue),¹ documents the most severe manifestation to date of systemic disease involving this lipophilic yeast. In addition to the case of peritonitis referred to in this article, there has also been a report of chronic sinusitis.² Although Redline and Dahms base their use of the term “malassezia” on the Manual of Clinical Microbiology,³ this work cites as its authority an article by Salkin and Gordon, who state that the term “Malassezia furfur” should be reserved for organisms possessing.